Bogart Wealth’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BBIO
Bogart Wealth's BBIO Position: Q3 2026 in Review
Bogart Wealth opened a new position in BridgeBio Pharma (BBIO) in Q3 2026: 7 shares worth $461. The stake represents ﹤0.01% of the portfolio and ranks #1846 among its holdings. This is a return to the name: Bogart Wealth previously reported a position in BBIO as recently as Q1 2026.
Bogart Wealth first reported a position in BBIO in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.9K in Q4 2025. 469 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.
- Bogart Wealth held 7 shares of BridgeBio Pharma worth $461 as of Q3 2026.
- BridgeBio Pharma was a new Bogart Wealth position in Q3 2026.
- BridgeBio Pharma made up ﹤0.01% of Bogart Wealth's portfolio in Q3 2026, its #1846 holding.
- Bogart Wealth first reported a position in BridgeBio Pharma in Q4 2025 and has held it in 3 quarters since.
- Bogart Wealth's BridgeBio Pharma position peaked at $4.9K in Q4 2025.
- 469 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.
Based on Bogart Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.